Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells
暂无分享,去创建一个
T. Beccari | S. Hunot | M. Garcia-Gil | F. Curcio | C. Arcuri | G. Traina | E. Albi | A. Lazzarini | S. Cataldi | B. Fioretti | Anna Tasegian | M. Codini | F. Ambesi-Impiombato | François-Pierre Légeron | C. Mecca
[1] D. Munoz,et al. Cytomegalovirus in the human dentate gyrus and its impact on neural progenitor cells: report of two cases. , 2017, Clinical Neuropathology.
[2] A. Klegeris,et al. Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer's and Parkinson's Diseases. , 2017, Current aging science.
[3] O. Manzoni,et al. Amplification of mGlu5-Endocannabinoid Signaling Rescues Behavioral and Synaptic Deficits in a Mouse Model of Adolescent and Adult Dietary Polyunsaturated Fatty Acid Imbalance , 2017, The Journal of Neuroscience.
[4] H. Reichmann,et al. Accelerated Age-Dependent Hippocampal Volume Loss in Parkinson Disease With Mild Cognitive Impairment , 2017, American journal of Alzheimer's disease and other dementias.
[5] L. Joseph,et al. Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis. , 2017, Chemico-biological interactions.
[6] P. Adlard,et al. Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion , 2017, Scientific Reports.
[7] C. Scherzer,et al. Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice , 2017, Molecular Neurodegeneration.
[8] L. Riboni,et al. Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids , 2017, Advances in Therapy.
[9] M. Garcia-Gil,et al. Nuclear Lipids in the Nervous System: What they do in Health and Disease , 2016, Neurochemical Research.
[10] J. Kornhuber,et al. Regulation of Neuronal Stem Cell Proliferation in the Hippocampus by Endothelial Ceramide , 2016, Cellular Physiology and Biochemistry.
[11] C. Bonhomme,et al. Dairy fat blend improves brain DHA and neuroplasticity and regulates corticosterone in mice. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.
[12] H. Car,et al. Regulation of sphingomyelin metabolism , 2016, Pharmacological reports : PR.
[13] T. Beccari,et al. e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease , 2016, Mediators of inflammation.
[14] C. Scavone,et al. Ouabain Modulates the Lipid Composition of Hippocampal Plasma Membranes from Rats with LPS-induced Neuroinflammation , 2015, The Journal of Membrane Biology.
[15] T. Beccari,et al. Very-long-chain fatty acid sphingomyelin in nuclear lipid microdomains of hepatocytes and hepatoma cells: can the exchange from C24:0 to C16:0 affect signal proteins and vitamin D receptor? , 2015, Molecular biology of the cell.
[16] M. Garcia-Gil,et al. Serum deprivation alters lipid profile in HN9.10e embryonic hippocampal cells , 2015, Neuroscience Letters.
[17] J. Suckling,et al. Multimodal MRI of the hippocampus in Parkinson’s disease with visual hallucinations , 2014, Brain Structure and Function.
[18] T. Beccari,et al. Analysis of Serum Sphingomyelin Species by Uflc-Ms/Ms in Patients Affected with Monoclonal Gammopathy , 2014 .
[19] L. Parnetti,et al. Lysosomal enzymes in PD: Further evidence is needed , 2014, Movement disorders : official journal of the Movement Disorder Society.
[20] N. Babenko,et al. Long-term food restriction prevents aging-associated sphingolipid turnover dysregulation in the brain. , 2014, Archives of gerontology and geriatrics.
[21] W. Shen,et al. Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi , 2013, Journal of Neuroinflammation.
[22] E. Clementi,et al. Sphingolipids and Brain Resident Macrophages in Neuroinflammation: An Emerging Aspect of Nervous System Pathology , 2013, Clinical & developmental immunology.
[23] F. Curcio,et al. Nuclear Lipid Microdomain as Place of Interaction between Sphingomyelin and DNA during Liver Regeneration , 2013, International journal of molecular sciences.
[24] A. Chattopadhyay,et al. Removal of sphingomyelin headgroup inhibits the ligand binding function of hippocampal serotonin1A receptors. , 2012, Biochemical and biophysical research communications.
[25] G. Massicotte,et al. Sphingomyelinase selectively reduces M1 muscarinic receptors in rat hippocampal membranes , 2012, Hippocampus.
[26] F. Marini,et al. Nuclear lipid microdomains regulate nuclear vitamin D3 uptake and influence embryonic hippocampal cell differentiation , 2011, Molecular biology of the cell.
[27] Y. Hannun,et al. Many Ceramides* , 2011, The Journal of Biological Chemistry.
[28] M. Mattson,et al. Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine‐1‐phosphate mediated mechanisms , 2010, Journal of neurochemistry.
[29] M. V. Magni,et al. Effect of 1α,25‐dihydroxyvitamin D3 in embryonic hippocampal cells , 2009, Hippocampus.
[30] E. Albi,et al. The nuclear ceramide/diacylglycerol balance depends on the physiological state of thyroid cells and changes during UV-C radiation-induced apoptosis. , 2008, Archives of biochemistry and biophysics.
[31] E. Albi,et al. Phosphatidylcholine/sphingomyelin metabolism crosstalk inside the nucleus. , 2008, The Biochemical journal.
[32] R. Donato,et al. Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles , 2002, Neuroscience.
[33] Y. Hannun,et al. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. , 1989, The Journal of biological chemistry.
[34] W. Hager,et al. and s , 2019, Shallow Water Hydraulics.
[35] R. Belli,et al. Sphingomyelin Turnover Induced by Vitamin D 3 in HL-60 Cells , 2001 .